| Literature DB >> 29426538 |
Diogo L R Novo1, Rodrigo M Pereira1, Carla A Hartwig1, Clarissa M M Santos1, Marcia F Mesko2.
Abstract
In this work a feasible method for chloride and sulfate determination in calcium carbonate pharmaceutical raw material and commercial tablets by ion chromatography after microwave-induced combustion was developed. The analytes were released from matrix by combustion in closed system pressurized with oxygen. Starch as volatilization aid, 100mmolL-1 HNO3 as absorbing solution and 5min of microwave irradiation time were used. Recovery tests using standard solutions were performed for the accuracy evaluation. A mixture of calcium carbonate pharmaceutical raw material or commercial tablets, starch and a certified reference material was also used as a type of recovery test. Recoveries ranging from 88% to 103% were obtained in both spike tests. Limits of detection (Cl-: 40µgg-1 and SO42-: 140µgg-1) were up to eighteen times lower than the maximum limits established for the analytes by Brazilian, British, European and Indian Pharmacopoeias. The limit tests recommended by the European Pharmacopoeia for Cl- and SO42- in CaCO3 were carried out to compare the results. Chloride and SO42- concentrations in the samples analyzed by proposed method were in agreement with those results obtained using the tests recommended by the European Pharmacopoeia. However, the proposed method presents several advantages for the routine analysis when compared to pharmacopoeial methods, such as the quantitative simultaneous determination, high sample preparation throughput (up to eight samples per run in less than 30min), reduced volume of reagents and waste generation. Thus, the proposed method is indicated as an excellent alternative for Cl- and SO42- determination in CaCO3 pharmaceutical raw material and commercial tablets.Entities:
Keywords: Inorganic impurities; Ion chromatography; Microwave-induced combustion; Pharmaceutical analysis; Sample preparation
Mesh:
Substances:
Year: 2018 PMID: 29426538 DOI: 10.1016/j.talanta.2018.01.040
Source DB: PubMed Journal: Talanta ISSN: 0039-9140 Impact factor: 6.057